Related Experiment Video
Updated: Apr 15, 2026
04:53
A Clinical Trial Assessing the Safety, Efficacy, and Delivery of Olive-Oil-Based Three-Chamber Bags for Parenteral Nutrition
Published on: September 20, 2019
11.5K
Positioning Community Pharmacies in Nigeria as a Clinical Trial Partner: A Forward Perspective
Adeboye O Bamgboye1,2, Ibrahim A Hassan2,3, Babatunde M Jinadu2,4
1Department of Experimental and Clinical Pharmacology, College of Pharmacy, University of Minnesota, Minneapolis, Minnesota, USA.
Clinical and Translational Science
|April 14, 2026
Summary
Decentralized clinical trials (DCTs) offer solutions for research in Nigeria. Utilizing community pharmacies can overcome infrastructure and recruitment hurdles in African clinical research.
Area of Science:
- Clinical research methodology
- Public health initiatives
- Pharmaceutical sciences
Background:
- Decentralized clinical trials (DCTs) represent an innovative shift from traditional site-based research.
- Low- and middle-income countries (LMICs) face significant challenges in clinical trial execution, including limited infrastructure, workforce shortages, and funding constraints.
- Nigeria, as an example LMIC, experiences these trial-related difficulties, hindering medical research advancement.
Purpose of the Study:
- To explore the potential of Decentralized Clinical Trials (DCTs) in overcoming common challenges in conducting clinical research within Nigeria.
- To identify how non-traditional healthcare infrastructure, specifically community pharmacies, can be integrated into DCT models.
- To assess the strategic value of Nigeria's extensive community pharmacy network as partners in decentralized research efforts.
Main Methods:
- Conceptual analysis of DCT models applied to LMIC contexts.
- Review of existing healthcare infrastructure in Nigeria, focusing on community pharmacies.
- Examination of potential benefits and challenges of leveraging community pharmacies for DCTs.
Main Results:
- DCTs offer a viable framework to mitigate infrastructural and manpower limitations in Nigerian clinical trials.
- Community pharmacies present an accessible, widespread resource that can be adapted for decentralized trial activities.
- Strategic partnerships with Nigerian community pharmacies can enhance patient recruitment and trial feasibility.
Conclusions:
- Decentralized clinical trials hold significant promise for advancing medical research in Nigeria and similar LMICs.
- Integrating community pharmacies into DCT frameworks can effectively address key logistical and operational barriers.
- Collaboration with community pharmacies is crucial for successful implementation of DCTs in resource-limited settings.
Related Concept Videos
01:11Clinical Trials: Overview
5.5K
Clinical development focuses on how the drug will interact with the human body and encompasses four key phases of clinical trials, each serving a specific purpose in assessing the safety and effectiveness of new drugs. These phases overlap and build upon one another. Phase I involves a small group of healthy volunteers (typically 20-80 individuals) or, in cases where significant toxicity is expected, patients with the targeted disease, such as cancer or AIDS. The volunteers are tested for...
5.5K
01:16Clinical Trials
11.2K
Clinical trials are prospective experimental studies conducted on humans to determine the safety and efficacy of treatments, drugs, diet methods, and medical devices. Using statistics in clinical trials enables researchers to derive reasonable and accurate conclusions from the collected data, allowing them to make wise decisions in uncertain situations. In medical research, statistical methods are crucial for preventing errors and bias.
There are four phases in a clinical trial. A phase one...
There are four phases in a clinical trial. A phase one...
11.2K
01:29Clinically Relevant Drug Product Specifications: Methods of Establishment
285
Product specifications define the acceptable quality of a pharmaceutical product by ensuring identity, purity, potency, and strength. These specifications serve as benchmarks during development, manufacturing, and post-approval quality control. Clinically relevant specifications are particularly important because they directly relate to a drug's safety and efficacy in clinical use.Dissolution studies are critical biopharmaceutic tools that link in vitro behavior to in vivo performance. They...
285
01:28Preclinical Development: Overview
6.5K
Preclinical development consists of a series of tests that ensure the safety and efficacy of a new therapeutic compound before it is tested in humans. There are four main phases to this process. First, safety pharmacology tests are conducted to ensure the drug does not produce any acutely harmful effects. These tests examine parameters such as bronchoconstriction, cardiac dysrhythmias, blood pressure changes, and ataxia. Next, preliminary toxicological testing is performed to determine the...
6.5K
01:02Prescription, Nonprescription and Orphan Drugs
1.4K
Prescription drugs require a prescription from a medical practitioner and can only be obtained from a pharmacy. They have many applications, including treating pain, anxiety, and hypertension.
The misuse and addiction to prescription drugs is a growing problem that can affect people of all age groups, specifically teenagers. This can happen when prescription medications are used in ways not intended by the prescriber, such as taking someone else's prescription or using medication for...
The misuse and addiction to prescription drugs is a growing problem that can affect people of all age groups, specifically teenagers. This can happen when prescription medications are used in ways not intended by the prescriber, such as taking someone else's prescription or using medication for...
1.4K
01:19Pharmacovigilance
2.0K
Post-marketing surveillance is a critical component of pharmaceutical regulation, often uncovering unanticipated adverse drug reactions (ADRs) once a drug is widely used over an extended period.
This process, termed pharmacovigilance, aims to detect, evaluate, and minimize harmful effects related to medication use. The data collection for pharmacovigilance depends on spontaneous reporting systems, where healthcare professionals or patients voluntarily report suspected ADRs.
In some cases, there...
This process, termed pharmacovigilance, aims to detect, evaluate, and minimize harmful effects related to medication use. The data collection for pharmacovigilance depends on spontaneous reporting systems, where healthcare professionals or patients voluntarily report suspected ADRs.
In some cases, there...
2.0K